ranolazine has been researched along with Allodynia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
El-Gawly, HW; El-Sherbeeny, NA; Elaidy, SM; Elkholy, SE; Toraih, EA | 1 |
Cho, SR; Diamond, I; Gould, HJ; Hernandez, C; Paul, D; Soignier, RD; Taylor, BK | 1 |
Casey, GP; Diamond, I; Gould, HJ; Paul, D; Roberts, JS | 1 |
3 other study(ies) available for ranolazine and Allodynia
Article | Year |
---|---|
Neuroprotective effects of ranolazine versus pioglitazone in experimental diabetic neuropathy: Targeting Nav1.7 channels and PPAR-γ.
Topics: Animals; Behavior, Animal; Comorbidity; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diet, High-Fat; Hyperalgesia; Inflammation; Interleukin-1beta; Male; NAV1.7 Voltage-Gated Sodium Channel; Neuroprotective Agents; Pioglitazone; PPAR gamma; Ranolazine; Rats; Rats, Wistar; Spinal Cord; Tumor Necrosis Factor-alpha | 2020 |
Ranolazine attenuates mechanical allodynia associated with demyelination injury.
Topics: Acetanilides; Animals; Demyelinating Diseases; Disease Models, Animal; Enzyme Inhibitors; Hyperalgesia; Male; Neuralgia; Piperazines; Ranolazine; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2014 |
Ranolazine attenuation of CFA-induced mechanical hyperalgesia.
Topics: Acetanilides; Administration, Oral; Animals; Enzyme Inhibitors; Foot; Freund's Adjuvant; Hot Temperature; Hyperalgesia; Injections, Intraperitoneal; Male; Pain Measurement; Physical Stimulation; Piperazines; Ranolazine; Rats; Rats, Sprague-Dawley | 2010 |